TPN 3:1, 3000 mL Bags, Qty: 7, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Water for...
FDA Drug Recall #D-1159-2015 — Class II — May 28, 2015
Recall Summary
| Recall Number | D-1159-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 28, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Lincare, Inc. |
| Location | Little Rock, AR |
| Product Type | Drugs |
| Quantity | 7 Bags |
Product Description
TPN 3:1, 3000 mL Bags, Qty: 7, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Water for Inj; Electrolytes Famotidine, MgSO4, KCL, NaC, Zinc Cl; Vitamins, trace elements and medications Multitrace-4, Multi Vitamin, Vitamin K, Ascorbic Acid, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.
Reason for Recall
Lack of Assurance of Sterility: Sterility of product is not assured.
Distribution Pattern
United States including: Arkansas
Lot / Code Information
All product compounded between May 14, 2015 and May 27, 2015
Other Recalls from Lincare, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1200-2015 | Class II | Morphine Sulfate, MORPHINE SULFATE 1000mg / NS ... | May 28, 2015 |
| D-1158-2015 | Class II | TPN 2:1, 200 ml Bags, Qty: 7, Base Formula NaCl... | May 28, 2015 |
| D-1188-2015 | Class II | Vancomycin, VANCOMYCIN 750mg / NS 100mL AccuFlo... | May 28, 2015 |
| D-1170-2015 | Class II | Fluorouracil 1400mg / D5W 278mL Qty: 1 278 mL B... | May 28, 2015 |
| D-1198-2015 | Class II | Potassium Chloride, Dextrose 5% LR 1000 mL with... | May 28, 2015 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.